UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinic ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025(Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodi ...

The AIM-traded firm said the NCI had identified multiple antibody-expressing cells that positively bind to their targets of interest using Fusion’s OptiMAL Library. It said it would now extract ...

After cell fusion, hybridoma cells were subcloned using limiting dilution ... Color development and readings were performed as described in Indirect ELISA. The method for conjugating antibodies with ...

Episode 2: In this episode of antibody insights we will discuss the high specificity and affinity of antibodies. Make sure to follow to see our upcoming episodes! #antibodyinsights # ...

Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company announced today that the New England Journal ...

Fusion Antibodies PLC - Belfast-based contract researcher that provides discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Expects revenue of around GBP1 ...

Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, provides an update on the OptiMAL ...

The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC ... one patient of increased creatinine, two patients of increased alkaline phosphatase and aspartate ...

As of 12:17:30 PM GMT. Market Open.

Center for Advanced Analytical Science, Guangzhou Key Laboratory of Sensing Materials and Devices, Guangdong Engineering Technology Research Center for Sensing Materials and Devices, School of ...